Novo Nordisk stock falls as Deutsche Bank downgrades shares to sell
Covered by 1 source · 1 article
Novo Nordisk shares fell on Thursday after Deutsche Bank downgraded the Danish drugmaker to Sell from Hold and lowered its price target, citing concerns over the company’s growth prospects. The company's US shares declined about 2% in tradi…
Covered by
